Millions of people around the world are still affected by the coronavirus pandemic, also known as COVID-19. As scientists scramble and increase efforts in developing and testing potential treatments and preventative measures, a new study suggests that CBD or cannabis may potentially become a cure for COVID-19.
Forbes reports some scientists are looking into the possibility of CBD becoming a COVID-19 cure or have some health benefits for those who are suffering from severe cases. The researchers then suggested that there are ways that cannabis-derived CBD could help severe coronavirus patients. One of which is the ability to reduce ACE2 expression and pro-inflammatory cytokine production that helps fight the inflammation of the lungs. Another is that it has the potential ability to be an antiviral treatment. However, not many studies have tested these theories.
But recently, the study from researchers at Georgia’s Augusta University suggests that CBD may benefit ARDS, also known as acute respiratory distress syndrome, which happens to be one of the severe symptoms of COVID-19. The researchers tested this theory on mice that were first given a dose of Poly(I:C) to artificially induce ARDS that has similar symptoms to COVID-19 patients. Once the mice were experiencing this syndrome, the researchers then gave them a dose of CBD. They noticed the impact CBD has in treating ARDS, which has resulted in a complete or semi-reversal of symptoms.
“Currently, other than supportive measures, there is no definitive cure for ARDS, illustrating the urgent need for creative and effective therapeutic modalities to treat this complex condition,” said the researchers. However, this study appears to add more weight to the possibility that CBD can be used as a possible cure for this dangerous symptom of COVID-19.
Meanwhile, according to the Russian representative for the World Health Organization Melita Vujnovic, it is possible that the virus may have been dormant all this time before it first broke out in Wuhan, China, in 2019. Chinese scientists, as well as the WHO has been looking into the origins of the virus by partnering to figure out where the virus came from.
Vujnovic explained that the virus was likely present in animals and somehow has passed onto humans. However, it proves difficult to specify when and where this all began.


FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 



